(XRAY) Dentsply Sirona - Ratings and Ratios

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is a global leader in the development, manufacturing, and marketing of dental and healthcare products, supported by cloud-enabled solutions. The company operates through four distinct segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. Its product portfolio spans imaging equipment, intraoral scanners, 3D printers, dental handpieces, endodontic tools, restorative products, orthodontic aligners, dental implants, and urology catheters. The company, founded in 1877 and headquartered in Charlotte, North Carolina, underwent a name change from DENTSPLY International Inc. to DENTSPLY SIRONA Inc. in February 2016 following strategic integration.

The Connected Technology Solutions segment focuses on advanced digital dentistry, offering CEREC for ceramic restorations, intraoral scanners, and 3D printing solutions. Essential Dental Solutions provides tools for root canal procedures, restorative materials, and dental diagnostics. Orthodontic and Implant Solutions includes clear aligners like SureSmile, implant products, and digital denture solutions. Wellspect Healthcare specializes in urology products, including intermittent catheters under the LoFric brand and Navina irrigation systems.

Technically, XRAY is trading at $13.87 with a 20-day average volume of 2.8M shares. The stock is below its 20-day SMA ($13.41) and 50-day SMA ($15.23), indicating bearish momentum. The 200-day SMA ($20.31) highlights a longer-term downtrend. ATR of 0.63 suggests moderate volatility. Fundamentally, the company has a market cap of $2.56B, a forward P/E of 6.95, and a P/S ratio of 0.67, signaling undervaluation. However, a negative RoE of -46.83% raises concerns about profitability.